Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Industry News

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

November 02, 2016

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Daily News

Good News, Bad News Week for Watchman LAA Occluder

Shelley Wood

November 12, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Caitlin E. Cox

January 28, 2015

News Daily News

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Todd Neale

December 11, 2014

News Daily News

得到的FDA专家组支持率低，Watchman可能为时不多了

L.A. McKeown

October 16, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Daily News

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

Yael L. Maxwell

June 28, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

Advertisement

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Good News, Bad News Week for Watchman LAA Occluder

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Hospital Volume Linked to More Favorable LAA Closure Outcomes

得到的FDA专家组支持率低，Watchman可能为时不多了

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content